MedPath

A research of efficacy and safety of aripiprazole treatment for the behavioral symptoms in subjects with pervasive developmental disordes.

Not Applicable
Conditions
Pervasive Developmental Disorders
Registration Number
JPRN-UMIN000006558
Lead Sponsor
Department of Neuropsychiatry, Faculty of Medical Sciences, University of Fukui
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Children less than 6 years old. 2. Participants were excluded if they had a history of major medical or neurological illness including epilepsy, significant head trauma, or a lifetime history of alcohol or drug dependence.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aberrant Behavior Checklist irritability
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath